Report copyright - Avelumab (MSB0010718C; anti-PD-L1) as a first-line ...medpub-poster.merckgroup.com/ASCO2016_9036.pdf · Avelumab 1 mgkg 2 Safety BO PS OS PD-L1 expression RESULTS • As of data cut-off
Please pass captcha verification before submit form